And so Masters what makes you the self proclaimed expert in terms of targets and acquirers of businesses ? While I agree that a bid will be someway off it is not beyond the realms of possibility if the ‘new mode of action’ starts to gain continued credibility. Fact - agrichem companies are desperately seeking out environmentally friendly alternatives that can combat pests that have developed resistance to current pesticides that haven’t been upgraded for 40 years. So from my 40 odd years in the corporate world my view is one of the majors ‘HAS TO’ either buy this solution and develop it into new products or take it out of the market so none of their competitors can ‘own’ the market. Let’s not forget what the big American Auto manufacturers and oil companies did back in the 1970’s when they bought out electric car start ups and shut those businesses down to ensure the combustion engine wasn’t at risk. Plenty of other examples of businesses at threat that buy out disrupters to preserve their mainstream business/es.
Testament to BioGene is the fact the are getting ready access to decision makers at some of Europe, China and US Aachen companies.
Agree with Lefevre. This will hit the radar screens of some big investors on the back of upcoming announcements, particularly the outcome of mosquito efficacy.
I took the opportunity to pick up a few more today.
BGT Price at posting:
15.5¢ Sentiment: Buy Disclosure: Held
